The availability of iPSC-derived cortical neurons from AD patients and the discovery of SGK1 and HDAC6 as key targets based on pathogenic mechanisms would stimulate further research and drug discovery in Alzheimer’s disease. This evidence concerns the gene HDAC6 and Alzheimer disease.